Presentation is loading. Please wait.

Presentation is loading. Please wait.

A FULLY IDENTIFIABLE PHYSIOLOGICAL MODEL OF INSULIN KINETICS FOR CLINICAL APPLICATIONS T Lotz 1, J G Chase 1, S Andreassen 2, C E Hann 1, J Lin 1, J Wong.

Similar presentations


Presentation on theme: "A FULLY IDENTIFIABLE PHYSIOLOGICAL MODEL OF INSULIN KINETICS FOR CLINICAL APPLICATIONS T Lotz 1, J G Chase 1, S Andreassen 2, C E Hann 1, J Lin 1, J Wong."— Presentation transcript:

1 A FULLY IDENTIFIABLE PHYSIOLOGICAL MODEL OF INSULIN KINETICS FOR CLINICAL APPLICATIONS T Lotz 1, J G Chase 1, S Andreassen 2, C E Hann 1, J Lin 1, J Wong 1 and K A McAuley 3 1 Department of Mechanical Engineering, University of Canterbury, Christchurch, New Zealand 2 Centre for Model-based Medical Decision Support, Aalborg University, Denmark 3 Edgar National Centre for Diabetes Research, University of Otago, Dunedin, New Zealand

2 Why model insulin kinetics? Glycaemic control for critically ill and Diabetes –Tight glycaemic control in ICU reduces mortality by up to 45% (Van den Berghe et al 2001) Diagnosis of insulin resistance –Requires knowledge of insulin kinetics Current models not physiological or difficult to identify!

3 Goals 1.Physiological accuracy Include key dynamics Parameters within physiological range 2.Useful in clinical applications Simple identification without the need of additional tests If possible population model

4 2-compartment insulin kinetics model + glucose pharmacodynamics PLASMA INTERSTITIAL FLUID KIDNEYS LIVER diffusion CELLS PANCREAS nCnC nKnK nLnL nInI u en u ex GLUCOSE

5 Similarities with C-peptide PLASMA V P INTERSTITIAL FLUID V Q KIDNEYS PANCREAS nKnK nInI u en PLASMA V P INTERSTITIAL FLUID V Q KIDNEYS LIVER CELLS PANCREAS nCnC nKnK nLnL nInI u en Additional losses C-peptide (Van Cauter et al 1992) Insulin

6 A priori parameter identification Similar molecular size and equimolar secretion of insulin and C-peptide Distribution volumes (V P, V Q ), transcapillary diffusion (n I ), kidney clearance (n K ) assumed to match values for C-peptide Parameters from well validated population model for C-peptide kinetics (Van Cauter et. al. 1992) Saturation of hepatic clearance (α I ) fixed from published literature Clearance by the cells fixed to achieve ss-concentration gradient between the compartments (I ss /Q ss =5/3) (Sjostrand et al 2005) 1 key insulin parameter to be estimated, liver clearance n L

7 Validation on clamps Euglycaemic clamp trials (N=146) Fitting errors within measurement noise: e G =5.9±6.6% SD e I =6.2±6.4% SD Correlation of clamp ISI with model S I : r=0.98 All parameters well within physiological range!

8 Validation on dose response test 10g glucose, 0.5U insulin Population insulin parameters Endogenous insulin estimated through C-peptide kinetics Hepatic clearance n L estimated from fasting information No need for additional insulin parameter estimation!

9 Conclusions Physiological insulin kinetics model Easy a-priori identification with C-peptide population model Additional fitting of key parameters (1 for insulin, 2 for glucose) Fits within measurement noise Great potential for use in clinical applications

10 Acknowledgements – Questions? Geoff ChaseGeoff Shaw Dominic Lee Steen Andreassen Jim Mann Kirsten McAuley Jessica LinChris HannJason Wong


Download ppt "A FULLY IDENTIFIABLE PHYSIOLOGICAL MODEL OF INSULIN KINETICS FOR CLINICAL APPLICATIONS T Lotz 1, J G Chase 1, S Andreassen 2, C E Hann 1, J Lin 1, J Wong."

Similar presentations


Ads by Google